Envestnet Asset Management’s Kite Pharma, Inc. KITE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-295
Closed -$53K 3071
2017
Q3
$53K Buy
+295
New +$41.1K ﹤0.01% 2271

Envestnet Asset Management's KITE Position: Q4 2017 in Review

Envestnet Asset Management sold out of Kite Pharma, Inc. (KITE) in Q4 2017, closing a stake of 295 shares — an estimated $53K sold.

Envestnet Asset Management first reported a position in KITE in Q3 2017 and held it in 1 quarter. The position peaked at $53K in Q3 2017. 0 funds tracked by Wall St. Rank hold KITE as of Q4 2017.

  • Envestnet Asset Management reported no remaining Kite Pharma, Inc. position as of Q4 2017 after selling out during the quarter.
  • Envestnet Asset Management sold 295 Kite Pharma, Inc. shares in Q4 2017, an estimated $53K.
  • Envestnet Asset Management first reported a position in Kite Pharma, Inc. in Q3 2017 and held it in 1 quarter.
  • Envestnet Asset Management's Kite Pharma, Inc. position peaked at $53K in Q3 2017.
  • 0 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2017.

Based on Envestnet Asset Management's 13F filing for Q4 2017, filed 20 Feb 2018.